hero section gradient
15 handpicked stocks

Targeting Superbugs: The Next Wave Of Antibiotics

GSK's new antibiotic for gonorrhea has received priority review from the FDA, underscoring the urgent need for new antimicrobial treatments. This event signals a potential resurgence in the market for companies developing novel antibiotics to address drug-resistant infections.

Author avatar

Han Tan | Market Analyst

Published on August 11

Your Basket's Financial Footprint

Structured summary and investor takeaways for the provided market capitalisation breakdown.

Key Takeaways for Investors:
  • Large-cap concentration generally implies lower volatility and more stable performance, closer to broad-market behaviour.
  • Suitable as a core holding for diversified portfolios rather than for speculative, concentrated bets.
  • Expect steady, long-term value growth rather than rapid, short-term upside; returns likely moderate.
Total Market Cap
  • ACXP: $11.11M

  • SPRO: $133.37M

  • ITRM: $35.26M

  • Other

About This Group of Stocks

1

Our Expert Thinking

The FDA's priority review of GSK's new antibiotic signals a pivotal moment for antimicrobial resistance solutions. This regulatory milestone highlights the critical public health crisis and may catalyse renewed investment in companies developing novel treatments for drug-resistant infections.

2

What You Need to Know

These biopharmaceutical companies operate at the cutting edge of medical science, advancing new mechanisms of action to overcome bacterial defences. The significant unmet medical need and potential for accelerated regulatory pathways could translate to substantial growth opportunities.

3

Why These Stocks

This collection was curated to feature firms with innovative pipelines aimed at high-priority pathogens. Each company offers tactical exposure to a biotech subsector poised for potential breakthroughs in combating antimicrobial resistance.

Why You'll Want to Watch These Stocks

🦠

Fighting The Superbug Crisis

Drug-resistant infections are becoming a global health emergency, creating massive demand for breakthrough treatments. These companies are racing to develop the next generation of life-saving antibiotics.

Fast-Track Regulatory Approval

The FDA's priority review process can accelerate drug approvals by months, potentially bringing successful treatments to market faster. This could mean quicker returns for investors backing the right innovations.

💎

Untapped Market Potential

With existing antibiotics losing effectiveness, there's enormous commercial opportunity for companies that crack the code on antimicrobial resistance. Early movers could capture significant market share.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Payroll Stocks: Could Gig Worker Rulings Drive New Demand?

Payroll Stocks: Could Gig Worker Rulings Drive New Demand?

A recent New Zealand Supreme Court ruling reclassified Uber drivers as employees, setting a major precedent for the global gig economy. This shift creates a potential investment opportunity in companies that provide essential payroll, benefits, and HR management services, which will be in higher demand as gig workers gain employment status.

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Frequently Asked Questions